This article introduces a practical approach to determining the best estimate for probability of passing uniformity of dosage units (content uniformity) using probability vs. lot coverage charts and tables constructed using simulated probability and lot coverage (LC1) data.
Submitted: August 24, 2020
Accepted: October 12, 2020
This article introduces a practical approach to determining the best estimate for probability of passing uniformity of dosage units (content uniformity) using probability vs. lot coverage charts and tables constructed using simulated probability and lot coverage (LC1) data. The best estimation concept is to demonstrate that the probability estimates, especially for those approaching 100%, are slightly different (deviated) from the exact calculated values by not more than (NMT) the statistically acceptable deviation limits.
Click here for a PDF of this articleSubmitted: Aug. 24, 2020
Accepted: Oct. 12, 2020
Pramote Cholayudth is an industrial pharmacist with more than 40 years of experiences. He is a guest speaker on Process Validation to industrial pharmaceutical scientists organized by Thailand’s FDA. He is the founder and manager of PM Consult and can be contacted via cpramote2000@yahoo.com.
Pharmaceutical Technology
Vol. 45, No. 5
May 2021
Pages: 36-43
When referring to this article, please cite it as P. Cholayudth, “Determining the Best Estimate of Probability of Passing Multiple Stage Tests: Part 1–Content Uniformity,” Pharmaceutical Technology 45 (5) 2021.
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.